Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2011; 17(31): 3605-3613
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3605
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3605
Figure 4 Effects of ginsenoside Rg3 on the cytochrome c release, caspase 8 cleavage and Bcl2-family.
Hep1-6 and HegG2 cells were treated with 0, 50, 100, 200 μg/mL ginsenoside Rg3 (Rg3) for 24 h, and western-blot was used to detect the pro-casepase-8, cytochrome c in cytosolic fractions (c) and mitochondria fractions (m), Bcl-2, Bcl-XL, Bax, and Bad. β-actin is the protein loading control. Pro-caspase-8 remains static with or without Rg3 treatment. Cytochrome c decreased in the mitochondrial fraction and increased in the cytosolic fraction. Bcl-2 and Bcl-XL were down-regulated while Bax was up-regulated. Bad remains unchanged in the cells with and without Rg3 treatment. Rg3: Ginsenoside Rg3.
-
Citation: Jiang JW, Chen XM, Chen XH, Zheng SS. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth
via intrinsic apoptotic pathway. World J Gastroenterol 2011; 17(31): 3605-3613 - URL: https://www.wjgnet.com/1007-9327/full/v17/i31/3605.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i31.3605